_esc-tv-at-acc-17-gemini-acs-1-low-dose-rivaroxaban-vs-aspirin-preview-1.jpg "ESC TV at ACC.17 - GEMINI ACS 1: Low Dose Rivaroxaban Vs Aspirin from www ema europa eu xarelto Video Screenshot Preview 1")
Gallery_esc-tv-at-acc-17-gemini-acs-1-low-dose-rivaroxaban-vs-aspirin-preview-3.jpg "ESC TV at ACC.17 - GEMINI ACS 1: Low Dose Rivaroxaban Vs Aspirin from www ema europa eu xarelto Video Screenshot Preview 3")
Gallery_esc-tv-at-acc-17-gemini-acs-1-low-dose-rivaroxaban-vs-aspirin-preview-hqdefault.jpg "ESC TV at ACC.17 - GEMINI ACS 1: Low Dose Rivaroxaban Vs Aspirin from www ema europa eu xarelto Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 4 minutes 46 seconds
👁 View: 648 times
Play Audio:👁 View: 648 times
Description:
European Society of Cardiology
European Society of Cardiology
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_european-medicines-agency-overview-124-marketing-authorisation-procedures-in-europe-ma-in-eu.webp "PHARMA PORTAL")
⏲ 12 minutes 27 seconds 👁 878
_european-medicines-agency-covid-19-public-meeting.webp "European Commission")
_learn-about-traineeship-opportunities-at-ema.webp "European Medicines Agency")
_is-rivaroxaban-safe-as-long-term-prevention-for-deep-vein-thrombosis.webp "American Society of Hematology")
_the-importance-of-the-european-medicines-agency-in-car-t-development.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_the-european-medicines-agency-and-patient-involvement-in-the-drug-approval-process.webp "Lung Cancer Europe")
⏲ 57 minutes 19 seconds 👁 255
_cost-analysis-rivaroxaban-vs-warfarin.webp "CSWNews")
_advancing-regulatory-science-in-europe.webp "European Medicines Agency")
_european-medicines-agency-overview-124-marketing-authorisation-procedures-in-europe-ma-in-eu.jpg)
_european-medicines-agency-covid-19-public-meeting.jpg)
_learn-about-traineeship-opportunities-at-ema.jpg)
_is-rivaroxaban-safe-as-long-term-prevention-for-deep-vein-thrombosis.jpg)
_the-importance-of-the-european-medicines-agency-in-car-t-development.jpg)
_the-european-medicines-agency-and-patient-involvement-in-the-drug-approval-process.jpg)
_cost-analysis-rivaroxaban-vs-warfarin.jpg)
_advancing-regulatory-science-in-europe.jpg)
![[+]](/images/menu.gif){kind=small}